Physical Health Monitoring for Patients Taking Antipsychotics

Free projects are complete and ready to use. Paid projects can also be adapted to your local requirements. This project uses a fixed Lazomis clinical configuration of 35 audit criteria across cohort and prescribing context, baseline and monitoring responsibility, core cardiometabolic monitoring, medication side-effect review, ECG and cardiovascular risk, action planning and interventions, and communication and continuity. Data collection, dashboards, findings, improvement planning, re-audit and every output are included at no cost.

• Psychiatrists, mental health nurses, GPs and practice nurses
• Clinical pharmacists, medicines optimisation and shared-care teams
• Community mental health, early intervention, learning disability and CAMHS teams
• QI, clinical governance and trainees needing ARCP-ready evidence

• Measure whether baseline and ongoing physical health monitoring is documented
• Review whether cardiometabolic measurements and blood tests are recorded within the expected period
• Review side-effect, movement disorder, prolactin and ECG considerations
• Review action planning, follow-up and communication of monitoring responsibility
• Generate governance-ready and ARCP-ready evidence

• Anonymised case number, care setting, clinical area, monitoring context and reviewer role
• Age band, indication group, treatment stage, route and monitoring responsibility
• Monitoring completeness, side effects reported, ECG status and abnormal findings
• Actions taken, engagement with monitoring and next review plan
• 35 fixed audit criteria (Yes / No / Not applicable, with Unable to determine where relevant)
• Free-text learning points

• Live dashboard
• Audit report (Word)
• Executive summary (Word)
• Excel workbook
• PowerPoint presentation
• Conference poster
• ARCP evidence summary

• Designed to use anonymised or pseudonymised audit identifiers.
• This tool supports, but does not replace, clinical judgement.
• Local policy, formulary and specialist advice should be followed.
• Organisations remain responsible for local governance arrangements.
• This tool supports clinical audit and quality improvement. It does not replace clinical judgement, local policy, specialist advice or urgent escalation pathways.
• This is not a prescribing guideline, not a medication-selection or dose-adjustment tool, and not a clozapine-specific monitoring system.
• Urgent physical health concerns, suspected serious adverse drug reactions, severe extrapyramidal symptoms, suspected neuroleptic malignant syndrome, acute dystonia, concerning ECG findings, severe cardiometabolic abnormality, safeguarding concern or pregnancy-related concern should be managed according to local urgent or specialist escalation pathways.
• Local antipsychotic prescribing, SMI physical health check, shared-care, medicines optimisation, ECG, prolactin, clozapine, safeguarding and escalation policies should be followed where applicable.
• Use anonymous case identifiers only — never patient-identifiable information.

Supporting guidance from the Lazomis QI Resource Library. Authoritative clinical standards referenced by this project remain separate.

• Clinical GovernanceIntegrating Quality Improvement into Clinical Governance FrameworksThis article explores the vital relationship between Quality Improvement (QI) and Clinical Governance within the NHS, demonstrating how they are two sides of the same coin when aiming for continuous, systematic improvement in patient care.
• Clinical GovernanceEffective Clinical Governance Meetings: Driving Improvement, Not Just ReportingThis guide helps NHS teams redefine their clinical governance meetings, moving beyond mere reporting to foster proactive discussion, shared learning, and tangible improvement actions for patient safety and quality of care.
• Quality ImprovementPlanning Effective PDSA Cycles for Quality ImprovementThis guide provides a practical, step-by-step approach to planning effective Plan-Do-Study-Act (PDSA) cycles for quality improvement initiatives within the NHS, focusing on robust design and learning. It covers essential considerations from defining your aim to anticipating challenges, helping teams systematically test changes.
• Quality ImprovementPDSA Cycles: A Practical Guide to Testing Change in HealthcareThis guide provides a practical overview of Plan-Do-Study-Act (PDSA) cycles, a fundamental tool for testing changes in healthcare quality improvement. It details how to apply PDSA effectively, common challenges, and integration with broader QI efforts.